Grade 3 treatment-related AEs included an increase in the alanine aminotransferase (ALT) level (4.7%), diarrhea (3.9%), anemia (3.1%), and an increase in the aspartate aminotransferase (AST) level (2.3%). The gene discussed is GPT; the disease is anemia.